Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-11-28FDA Approved: CYSVIEW — Supplemental Application (Photocure Inc.)
The FDA approved a supplemental application for CYSVIEW (hexaminolevulinate hydrochloride) from Photocure Inc., expanding its labeling/indic…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Adjuvant Post-radical Cystectomy Treatment for Bladder Cancer [Phase 3]
Phase 3 trial evaluating adjuvant therapy after radical cystectomy for bladder cancer has completed.
-
FDA approval · 2012-11-13FDA Approved: CISPLATIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for cisplatin filed by Fresenius Kabi USA, LLC. This action confirms the continued approval of cispl…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy [Phase 2]
A completed Phase 2 clinical trial (S0306) evaluating irinotecan in patients with recurrent or refractory advanced transitional cell cancer …
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium [Phase 2]
Phase 2 trial of Romidepsin (FR901228) in advanced urothelial cancers was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Detection of Bladder Tumors After 30 Min Instillation of Hexvix [Phase 2]
A Phase 2 trial investigating detection of bladder tumors after a 30-minute instillation of Hexvix was terminated.
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium [Phase 2]
Phase 2 trial evaluating neoadjuvant quadruple chemotherapy (Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin) before radical cystectomy …
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes
A Takeda-sponsored cohort study evaluating pioglitazone in patients with type 2 diabetes for bladder cancer risk; the trial is completed and…
-
CLINICAL_TRIALS trial_result · 2012-10-08Clinical Trial Update: S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]
Phase 2 trial update for S0031 (ZD 1839/Gefitinib) in advanced urinary tract cancers; the study is completed, evaluating activity in bladder…
-
CLINICAL_TRIALS research · 2012-10-03Clinical Trial Update: Evaluation of Ultrasound Probe for Use in Bladder Radiotherapy
This document provides an update on an ongoing clinical trial evaluating an ultrasound probe for use in bladder radiotherapy.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: BCG With or Without Mitomycin in Treating Patients With Bladder Cancer [Phase 2]
Phase 2 trial evaluating Bacillus Calmette-Guérin with or without Mitomycin C for bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract [Phase 2]
Phase 2 trial of Nitrocamptothecin for metastatic cancer of the urinary tract has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer [Phase 3]
A Phase 3 trial evaluating chemotherapy with or without surgery in bladder cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]
A Phase 2 clinical trial evaluating SCH 66336 (lonafarnib) in combination with gemcitabine for advanced cancers of the urinary tract has com…
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder [Phase 2]
A Phase 2 study evaluating pralatrexate for advanced or metastatic relapsed transitional cell carcinoma of the urinary bladder has completed…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Tesetaxel for Previously Treated Patients With Bladder Cancer [Phase 2]
Phase 2 clinical trial update for Tesetaxel in previously treated bladder cancer (transitional cell carcinoma) patients; the trial status is…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Phase II Trial of EOquin in High-risk Superficial Bladder Cancer [Phase 2]
Phase II trial results for EOquin in high-risk superficial bladder cancer have been completed.
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer [Phase 3]
A Phase III randomized trial comparing Leukine (sargramostim) and Neupogen (filgrastim) in patients with bladder/urothelial cancer receiving…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Efficacy of Diclofenac BCG Irrigations [Phase 3]
Phase 3 trial update evaluating diclofenac BCG irrigations for bladder cancer; no efficacy results or current status are disclosed in the sn…
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder [Phase 1]
Phase 1 study evaluating Mycobacterium w in patients with BCG-refractory superficial transitional cell carcinoma of the bladder has been com…
-
FDA approval · 2012-03-15FDA Approved: CISPLATIN — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for cisplatin from Teva Parenteral Medicines, Inc., marking an approved change to the drug's regulat…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Safety and Pharmacokinetic Study of EO9(Intravesical Instillation) [Phase 1]
Phase 1 safety and pharmacokinetic study of EO9 administered via intravesical instillation for bladder cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer [Phase 3]
Phase 3 trial S9809 comparing ciprofloxacin with cephalexin for bladder cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer [Phase 2]
A Phase 2 trial evaluating transurethral resection with combination chemotherapy for Stage II/III bladder cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer [Phase 2]
A Phase 2 trial evaluating post-surgery radiation therapy with chemotherapy for stage II or stage III bladder cancer has been terminated.